News

The development of drug delivery platforms that offer sustained release of therapeutic agents in the retina represents a ...
In July 2025, CSL Behring conducted a study in China is to investigate the pharmacokinetics (PK) of rVIII-SingleChain after ...
A new study published in the Nature Scientific Reports showed that compared to kidney recipients who got preemptive transplants, individuals who experienced dialysis prior to transplantation are ...
A review reveals dangerous vitamin deficiencies post-bariatric surgery, highlighting the need for improved follow-up to ...
Meredith R. Klifto, MD, is an assistant professor of ophthalmology at the University of North Carolina School of Medicine, Chapel Hill. As a board-certified ophthalmologist, she specializes in ...
These four Dividend Aristocrats are Buy-rated sector leaders with yields above 3%. Passive income investors can buy and hold ...
Here are four high-yield blue-chip pharmaceutical stocks positioned to outperform and offer huge total return potential.
Peer ReviewDownload a summary of the editorial decision process including editorial decision letters, reviewer comments and ...
Hello, readers! Welcome to a bonus letters column. We are happy to report that you are keeping our inboxes busy, so we’ll dive right in.